The Arthritis Therapeutics Market Is Estimated To Grow 1.5x During By 2027: Fact.MR Analysis

Rockville , March 06, 2023 (GLOBE NEWSWIRE) -- The global arthritis therapeutics market would expand 1.5 times from 2020 to 2027 . Patients in Europe and North America would push demand for therapeutics. They are looking for early diagnosis to prevent fatalities.

Rising prevalence of arthritis is a key factor fueling the arthritis therapeutics market. Increased funding from private and government agencies for development of new therapies would also augment sales.

Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4355

Key Takeaways:

Growth Drivers:

Key Companies Profiled by Fact.MR

Get Customization on this Report for Specific Research Solutions : https://www.factmr.com/connectus/sample?flag=RC&rep_id=4355

Competitive Landscape:

As per Fact.MR, the arthritis therapeutics market would be dominated by a few key companies. They are focusing on research and development activities. They are also striving to come up with novel drugs to strengthen their position in the industry.

For instance,

Research centers worldwide are striving to come up with novel therapeutics to offer better treatment options. Manufacturers are promising new product and pipeline project launches. They are also creating novel awareness campaigns, especially in remote areas.

For instance, in 2018, the National Library of Medicine published a new treatment for osteoarthritis. It mentioned that treatment is possible with mesenchymal stem cell therapy.

Around 500 government-registered clinical trials are evaluating the safety and efficiency of adult stem cells. These include the umbilical cord, pluripotent, and mesenchymal stem cells, to treat osteoarthritis.

According to data released by the Centers for Disease Control and Prevention (CDC), around 78.4 million adults in the USA would live with doctor-diagnosed arthritis by 2040. From 2013 to 2015, there were 58.5 million adults with the disease. Hence, demand for innovative therapeutics would expand by 2027.

Technological advancements in the field of arthritis would further augment demand. Easy availability of better treatment options would also create new opportunities.

In June 2021, the USA Food and Drug Administration announced the sanction of CyMedica's IntelliHub system. It is designed to treat pain caused by debilitating knee arthritis. Hence, fast track approvals by government agencies would help the market to expand.

However, risks associated with non-steroidal anti-inflammatory drugs might limitdevelopment in the arthritis therapeutics market. Their side effects include dizziness, stomach ulcers, and allergic reactions. Coupled with this, availability of drugs for the treatment of arthritis would hamper demand for therapeutics.

Based on distribution channels, hospital pharmacies account for a significant share of the global market. Increasing patients visiting hospitals for arthritis treatment would bode well for the segment. Easy availability of a wide variety of arthritis medications at these pharmacies would also drive sales.

More Valuable Insights on Arthritis Therapeutics Market

In the up-to-date study, Fact.MR reveals key factors expected to boost development in the global arthritis therapeutics market during the forecast period (2019 to 2027). The analysis also provides an in-depth study of opportunities and drivers projected to propel sales of arthritis therapeutics through detailed segmentation as follows:

Type:

Drug Class:

Route of Administration

Distribution Channel:

Regions:

Quick Buy & Expand Your Horizons: https://www.factmr.com/checkout/4355

Key Questions Covered in the Arthritis Therapeutics Market Report

Explore Fact. MRs Coverage in the Healthcare Domain

Rheumatoid Arthritis Stem Cell Therapy Market: The global rheumatoid arthritis stem cell therapy market reached US$ 23.42 billion in 2022. The market would surpass a valuation of US$ 33.30 billion by 2032. It would further surge at a CAGR of 4.5% from 2022 to 2032.

Bilateral Osteoarthritis Treatment Market: The market for bilateral osteoarthritis treatment would expand at a rapid pace over the forecast period. Rising prevalence of bilateral osteoarthritis across the globe would drive demand in the market.

Axial Spondyloarthritis Market: Rising incidence of axial spondyloarthritis is propelling growth in the global axial spondyloarthritis market. Prevalence of axial spondyloarthritis in North America would elevate by 2030.

Genetic Disorder Therapeutics Market : According to US Food & Drug Administration, nearly 7,000 genetic diseases affects more than 30 million people. Around 75%-80% of genetic diseases are caused by a single-gene defect, and some of genetic diseases affects children.

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our clients satisfaction.

Subscribe Our Weekly Newsletter for the Latest Updates : Fact.MR Talks

Contact: US Sales Office 11140Rockville Pike Suite 400 Rockville, MD20852 United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D) E: sales@factmr.com

Follow Us: LinkedIn | Twitter | YouTube

Follow this link:
The Arthritis Therapeutics Market Is Estimated To Grow 1.5x During ... - InvestorsObserver